Summary:
- Intuitive Surgical (ISRG, Financial) delivers impressive Q2 2025 results with significant revenue and earnings growth.
- Analysts remain optimistic with an average price target implying notable upside potential.
- Current market conditions yield an "Outperform" recommendation from leading brokerage firms.
Intuitive Surgical (ISRG) recently announced its financial achievements for the second quarter of 2025, demonstrating vigorous growth with a 21% increase in revenue and a 23% rise in pro forma earnings per share. CEO David J. Rosa attributed this success to the effective launch and widespread adoption of the da Vinci 5 system, marked by 395 new installations this quarter. Reflecting diverse international market dynamics, the company has revised its annual procedure growth forecast to a range of 15.5% to 17%.
Wall Street Analysts Forecast
According to 27 analyst projections, Intuitive Surgical Inc (ISRG, Financial) has a one-year average target price of $587.27. This estimate spans from a high of $675.00 to a low of $440.00, suggesting a potential upside of 14.93% from the current trading price of $511.00. Investors looking for more granular data can explore the Intuitive Surgical Inc (ISRG) Forecast page for further insights.
In the realm of brokerage firm assessments, Intuitive Surgical Inc's (ISRG, Financial) average brokerage recommendation stands at 2.1, signifying an "Outperform" status. The recommendation scale varies from 1, indicating a Strong Buy, to 5, denoting a Sell.
Utilizing GuruFocus metrics, the estimated GF Value for Intuitive Surgical Inc (ISRG, Financial) in one year is calculated at $510.97, which indicates a slight downside of 0.01% from the present price of $511. The GF Value reflects GuruFocus' assessment of the fair stock value based on historical trading multiples, prior business growth, and projected future performance. For additional detailed information, visit the Intuitive Surgical Inc (ISRG) Summary page.
